Exec. VP and CLO of PTC THERAPEUTICS, INC. (U.S.: Nasdaq:PTCT), Boulding Mark Elliott, sells 885 shares worth $34,095
According to PTC THERAPEUTICS, INC.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:19 PM, company Exec. VP and CLO, Boulding Mark Elliott disclosed selling 885 shares at a cost of $38.52. At the time of this transaction (Jan 07), this trade was worth $34,095 in total. As of Jan 07, Boulding Mark Elliott now owns 47,489 shares in total worth about $1,925,204.06.
For the last few recent trades made by PTC THERAPEUTICS, INC. (U.S.: Nasdaq:PTCT) Exec. VP and CLO, Boulding Mark Elliott, we have the following information:
- SEC Form 4 filing: Sep 02: Sold 3,363 shares at the rate of $45.01 per share. Total worth of this trade was $151,375. Total number of shares owned as of Sep 02 were 48,374
- SEC Form 4 filing: Jul 08: Sold 7,805 shares at the rate of $45.22 per share. Total worth of this trade was $352,968. Total number of shares owned as of Jul 08 were 48,374
- SEC Form 4 filing: Jul 09: Sold 1,429 shares at the rate of $45.00 per share. Total worth of this trade was $64,306. Total number of shares owned as of Jul 09 were 48,374
Posted by
George Daniels
on Tuesday January 11 2022, 11:03 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
